Class II
Ongoing
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Why: Lack of Assurance of Sterility
- Company
- PAYLESS COMPOUNDERS, LLC
Beaverton, OR, United States - Reported
- Apr 22, 2026
- Recall started
- Mar 6, 2026
- Where sold
- OR
- Amount
- 91 vials
- Full product description
- Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
- Lots / codes affected
- Lot Number 01-27-2026@14S.5
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.